J.W. Cole Advisors’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-15,803
| Closed | -$370K | – | 996 |
|
|
2024
Q3 | $370K | Buy |
15,803
+103
| +0.7% | +$2.41K | 0.02% | 707 |
|
|
2024
Q2 | $279K | Sell |
15,700
-3,659
| -19% | -$65.1K | 0.01% | 727 |
|
|
2024
Q1 | $294K | Buy |
19,359
+700
| +4% | +$10.6K | 0.01% | 698 |
|
|
2023
Q4 | $319K | Hold |
18,659
| – | – | 0.02% | 628 |
|
|
2023
Q3 | $156K | Hold |
18,659
| – | – | 0.01% | 696 |
|
|
2023
Q2 | $463K | Hold |
18,659
| – | – | 0.03% | 446 |
|
|
2023
Q1 | $281K | Buy |
18,659
+3,659
| +24% | +$55K | 0.02% | 623 |
|
|
2022
Q4 | $177K | Hold |
15,000
| – | – | 0.01% | 698 |
|
|
2022
Q3 | $89K | Hold |
15,000
| – | – | 0.01% | 698 |
|
|
2022
Q2 | $64K | Hold |
15,000
| – | – | 0.01% | 712 |
|
|
2022
Q1 | $143K | Hold |
15,000
| – | – | 0.01% | 769 |
|
|
2021
Q4 | $285K | Hold |
15,000
| – | – | 0.02% | 670 |
|
|
2021
Q3 | $499K | Buy |
+15,000
| New | +$499K | 0.04% | 260 |
|